customerservice@curanthealth.com
866-460-8040

Upcoming Events

August 18, 2025
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Atlanta, GA – August 18, 2025 – Curant Health is proud to announce that Curant Rare is now the exclusive pharmacy partner for IWILFIN™, a groundbreaking therapy used to reduce the risk of relapse in adults and children with high-risk neuroblastoma (HRNB). Beginning in August 2025, patients will transition to Curant Rare with one clear […]

Read More
February 7, 2025
Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care

ATLANTA--(BUSINESS WIRE)--Curant Health, a multifaceted Medication Care Management® organization, dedicated to the care of complex patients nationwide, is proud to announce the launch of our Curant Rare™ business unit. Curant Rare™ utilizes our complex care patient services and unmatched business intelligence capabilities within our award-winning specialty pharmacy platform to improve the clinical health outcomes of patients suffering from […]

Read More
September 9, 2021
Curant Health and Humana Launch Pilot Program to Address Medication Adherence and Enhance Patient Care for Members with Complex Health Needs

Wed, September 8, 2021, 10:00 AM·3 min read LOUISVILLE, Ky., September 08, 2021--(BUSINESS WIRE)--Curant Health and Humana Inc. (NYSE: HUM) have teamed up to help achieve better health outcomes for Humana members suffering from Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). The new pilot program, aimed at improving medication adherence in order to help patients […]

Read More
menu-circlecross-circle Skip to content